logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11911409 B1

PDFFull Text
Date of Patent:
Feb. 27, 2024

Filed:

Oct. 20, 2021

Pharmaceutical composition for treatment and prevention of chronic disease

Applicant:

Stelic Institute & Co., Inc., Tokyo, JP;

Inventor:

Hiroyuki Yoneyama, Minato-ku, JP;

Assignee:

STELIC INSTITUTE & CO., INC., Tokyo, JP;

Attorney:

Oblon, McClelland, Maier & Neustadt, L.L.P.

Primary Examiner:

Amy H Bowman

Int. Cl.
CPC ...
C07H 21/04 (2006.01); A61K 31/7105 (2006.01); A61K 31/711 (2006.01); A61K 31/713 (2006.01); A61K 38/13 (2006.01); A61P 1/00 (2006.01); A61P 37/06 (2006.01); C07K 16/28 (2006.01); C12N 15/113 (2010.01); A61K 45/06 (2006.01); C12N 15/63 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7105 (2013.01); A61K 31/711 (2013.01); A61K 31/713 (2013.01); A61K 38/13 (2013.01); A61P 1/00 (2018.01); A61P 37/06 (2018.01); C07K 16/2839 (2013.01); C12N 15/113 (2013.01); A61K 45/06 (2013.01); C12N 15/63 (2013.01); C12N 2310/14 (2013.01);
Abstract

An object of the present invention is to develop a novel treatment method for chronic diseases for which conventional treatment methods are either ineffective or for which efficacy is low. The present invention provides a pharmaceutical composition for the treatment and/or prevention of an inflammatory chronic disease that is used in combination with a biological preparation that inhibits leukocyte tissue invasion. The pharmaceutical composition of the present invention contains as an active ingredient thereof siRNA suppressing the expression of CHST15 gene that contains a structure formed by the hybridization of RNA containing the base sequence represented by SEQ ID NO: 1 with RNA complementary thereto.

Find Patent Forward Citations

Loading…